Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-03-01 @ 3:01 PM
Study NCT ID:
NCT03840902
Status:
TERMINATED
Last Update Posted:
2024-01-16
First Post:
2019-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Sponsor:
EMD Serono Research & Development Institute, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-16
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-17
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-12
First Submit QC Date:
None
Study First Post Date:
2019-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-05
Results First Submit QC Date:
None
Results First Post Date:
2024-01-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-12
Last Update Post Date:
2024-01-16
Last Update Post Date Type:
ACTUAL